J Breast Cancer.  2006 Dec;9(4):361-366. 10.4048/jbc.2006.9.4.361.

Complementary and Alternative Medicine in Patients with Breast Cancer

• Chung HJ
• Kim MR
• Bae JS
• Park WC
• Song BJ
• Kim JS
• Jung SS

• KMID: 2286610
• DOI: http://doi.org/10.4048/jbc.2006.9.4.361

Abstract

PURPOSE: The aim of this study is to evaluate the use of complementary and alternative medicine (CAM) by the breast cancer patients in Korea.
METHODS
A total of 160 patients with breast cancer answered a questionnaire about CAM use after their diagnosis of breast cancer. All the patients answered a 29-item questionnaire that included about sociodemographic characteristics of the users, the types of CAM, duration of use, the cost, reasons, sources of information and the benefits for using CAM.
RESULTS
Most sociodemographic characteristics showed no significant difference between the users and non-users of CAM. Almost four fifth of the patients using CAM were between 40 and 60 years, married and had a high school education or above. The use of any type of CAM was admitted by 58 patients (36%). The most commonly used CAM was "health food" (67%). 9% of CAM users had been using CAM before the diagnosis of breast cancer, 19% since diagnosis of cancer and 70% after their breast surgery. For the duration of CAM usage, 56% patients used CAM less than 12 months. For using of CAM, 44% had spent 100,000 - 500,000 Korean won per month on CAM. For the source of information about the use of CAM, 46% of CAM users mentioned their family members, 30% from friends, 26% from media, 15% from her physician, and 9% mentioned other patients. 80% of the used CAM users do not discus their CAM usage with their physician and they use CAM along with their conventional treatment simultaneously. 69% of the CAM users perceived that CAM was helpful for their recovery and 84% of CAM users said their use of CAM will continue.
CONCLUSION
Some of the patients in this study, but 80% of the patients that used CAM do not discus this with their physician during conventional treatment. Therefore, physician should query about CAM and they should be able to recommend the use of proper CAM to their patients.

Keyword

Complementary Therapies; Breast Neoplasms

MeSH Terms

Breast Neoplasms*
Breast*
Complementary Therapies*
Diagnosis
Education
Friends
Humans
Korea
Surveys and Questionnaires

Reference

1. National Center for Complementary and Alternative Medicine:What is complementary and alternative medicine. Accessed 9 January 2004. Available from http://nccam.nih.gov/health/whatiscam.

2. Cassileth BR, Schraub S, Robinson E, Vickers A. Alternative medicine use worldwide: the International Union Against Cancer Survey. Cancer. 2001. 91:1390–1393.

3. Ernst E, Cassileth BR. The prevalence of complementary/ alternative medicine in cancer: a systematic review. Cancer. 1998. 83:777–782.

4. Fernandez C, Pyesmany A, Stutzer C. Alternative therapies in childhood cancer. N Engl J Med. 1999. 340:569–570.

5. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999. 340:1733–1739.

6. DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002. 20:34S–38S.

7. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol. 1998. 16:6–12.

8. Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000. 179:407–411.

9. Kraut AM. Healers and strangers. Immigrant attitudes toward the physician in America - a relationship in historical perspective. JAMA. 1990. 263:1807–1811.

10. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000. 92:42–47.

11. Tagliaferri M, Cohen I, Tripathy D. Complementary and alternative medicine in early-stage breast cancer. Semin Oncol. 2001. 28:121–134.

12. Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol. 2002. 29:563–574.

13. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci. 2002. 23:136–139.

14. Markman M. Safety issues in using complementary and alternative medicine. J Clin Oncol. 2002. 20:39S–41S.

15. Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994. 309:86–89.

16. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001. 2:533–543.

17. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000. 18:2515–2521.

18. Lee Sang-Il, Khang Young-Ho, Lee Moo-Sang, Koo Hee-Jo, Kang Wee Chang, Hong Chang Gi. Complementary and alternative medicine use in Korea: prevalence, pattern of use, and out-of-pocket expenditures. Korean J Prev Med. 1999. 32:546–555.

19. Lee Kun Sei, Ahn Hyung Sik, Hwang La Il, Lee Young Sung, Koo Bum Hwan. Utilization of alternative therapies in cancer patients. Cancer Res Treat. 1998. 30:203–213.

20. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States 1990-1997: results of a follow-up national survey. JAMA. 1998. 280:1569–1575.

21. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000. 18:2505–2514.

22. Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C. Prevalence of complementary therapy use by women with breast cancer. A population-based survey. Eur J Cancer. 2000. 36:1359–1356.

23. Jacobson JS, Workman SB, Kronenberg F. Research on complementary /alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol. 2000. 18:668–683.